2021 annual financial data
Coherus Oncology 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -11.46%.
Operating income was -263,858,000 USD and net income was -287,100,000 USD.
Operating cash flow was -37,432,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 326,551,000 USD
- Operating income
- -263,858,000 USD
- Net income
- -287,100,000 USD
- Operating cash flow
- -37,432,000 USD